Eletriptan hydrobromide
| Title | Journal |
|---|---|
| Quantitative analysis of eletriptan in human plasma by HPLC-MS/MS and its application to pharmacokinetic study. | Analytical and bioanalytical chemistry 20111101 |
| Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study. | Journal of clinical psychopharmacology 20110601 |
| BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. | Cephalalgia : an international journal of headache 20110401 |
| Cluster headache following dental treatment: a case report. | Journal of oral science 20110301 |
| Drug dependence associated with triptans and ergot derivatives: a case/non-case study. | European journal of clinical pharmacology 20100401 |
| Perimenstrual eletriptan prevents menstrual migraine: an open-label study. | Headache 20100401 |
| Real-life experiences in migraine therapy. | Bratislavske lekarske listy 20100101 |
| A case of ocular hypertension complicated by SUNCT syndrome. | Annals of ophthalmology (Skokie, Ill.) 20100101 |
| Eletriptan. | Expert opinion on drug metabolism & toxicology 20091201 |
| Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method. | Journal of pharmaceutical and biomedical analysis 20091101 |
| Large-scale screening and subsequent effects of migraine treatment on the work floor in the Netherlands. | Cephalalgia : an international journal of headache 20090601 |
| Treatment of sinus headache as migraine: the diagnostic utility of triptans. | The Laryngoscope 20081201 |
| Halide salts of antimigraine agents eletriptan and naratriptan. | Acta crystallographica. Section C, Crystal structure communications 20081201 |
| Triptans: actions and reactions. | Headache 20080401 |
| Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database. | Headache 20080201 |
| Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. | Cephalalgia : an international journal of headache 20080101 |
| Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. | International journal of clinical practice 20071001 |
| Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. | Headache 20070501 |
| Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. | Headache 20070401 |
| Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. | Headache 20070301 |
| Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis. | Headache 20070201 |
| Eletriptan: a review and new perspectives. | Expert review of neurotherapeutics 20061001 |
| Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study. | Clinical therapeutics 20060801 |
| [Triptanes in the treatment of migraine. A review based on three Cochrane reviews]. | Ugeskrift for laeger 20060508 |
| Does earlier headache response equate to earlier return to functioning in patients suffering from migraine? | Cephalalgia : an international journal of headache 20060401 |
| Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. | Cephalalgia : an international journal of headache 20060301 |
| [Medical treatment of migraine attacks in the child]. | Revue de l'infirmiere 20060101 |
| Safety and efficacy of eletriptan in the treatment of acute migraine. | Pharmacotherapy 20060101 |
| Eletriptan: a review of its use in the acute treatment of migraine. | Drugs 20060101 |
| Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. | Headache 20060101 |
| Spotlight on eletriptan in migraine. | CNS drugs 20060101 |
| Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries. | European journal of clinical pharmacology 20051101 |
| Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. | Clinical science (London, England : 1979) 20050901 |
| Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation. | Cephalalgia : an international journal of headache 20050901 |
| Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. | Cephalalgia : an international journal of headache 20050901 |
| Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. | Cephalalgia : an international journal of headache 20050901 |
| Multiple attack study on the available triptans in Italy versus placebo. | European journal of neurology 20050701 |
| Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. | Journal of managed care pharmacy : JMCP 20050601 |
| Eletriptan review. | Expert opinion on pharmacotherapy 20050401 |
| Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan. | European journal of neurology 20050201 |
| pH-mediated acid stacking with reverse pressure for the analysis of cationic pharmaceuticals in capillary electrophoresis. | Electrophoresis 20050201 |
| Eletriptan in migraine. | Expert review of neurotherapeutics 20050101 |
| Which is more elusive, the pot of gold at the end of a rainbow or determining the most cost-effective triptan? | Journal of managed care pharmacy : JMCP 20050101 |
| [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal]. | Acta medica portuguesa 20050101 |
| No effect of eletriptan administration during the aura phase of migraine. | European journal of neurology 20041001 |
| [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]. | Neurologia (Barcelona, Spain) 20041001 |
| TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. | Acta neurologica Scandinavica 20040901 |
| [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. | No to shinkei = Brain and nerve 20040901 |
| [Triptans in migraine: from clinical view]. | No to shinkei = Brain and nerve 20040901 |
| [Meta-analysis of triptan treatment in migraine]. | No to shinkei = Brain and nerve 20040901 |
| [Side effects of triptans]. | No to shinkei = Brain and nerve 20040901 |
| Meta-analysis of oral triptans. | Cephalalgia : an international journal of headache 20040801 |
| Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. | Naunyn-Schmiedeberg's archives of pharmacology 20040701 |
| Cardiovascular safety of triptans. | Cephalalgia : an international journal of headache 20040701 |
| Effect of high-dose intravenous eletriptan on coronary artery diameter. | Cephalalgia : an international journal of headache 20040701 |
| Migraine headache. | Clinical evidence 20040601 |
| Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. | Cephalalgia : an international journal of headache 20040501 |
| Eletriptan for the short-term prophylaxis of cluster headache. | Headache 20040401 |
| Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders. | Headache 20040301 |
| Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials. | Current medical research and opinion 20040301 |
| The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. | Brain research 20040213 |
| [Use of triptanes according to indications. Risk of infarct is not increased]. | MMW Fortschritte der Medizin 20040212 |
| [Recent progress in therapy for migraine headache]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040210 |
| The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg. | European journal of neurology 20040201 |
| New drugs 04, part 1. | Nursing 20040201 |
| Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. | Cephalalgia : an international journal of headache 20031201 |
| Migraine headache. | Clinical evidence 20031201 |
| Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. | Cephalalgia : an international journal of headache 20031101 |
| Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review. | Headache 20031001 |
| Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs. | Headache 20031001 |
| Unilateral time-delayed encapsulation does not make for a fair race. | Headache 20030901 |
| Encapsulated sumatriptan is not bioequivalent to commercial sumatriptan. | Headache 20030901 |
| Musing on Mathew et al. | Headache 20030901 |
| [Strong and sustained-acting triptan. Therewith migraine does not return soon]. | MMW Fortschritte der Medizin 20030807 |
| Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. | Cephalalgia : an international journal of headache 20030701 |
| Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. | Drug metabolism and disposition: the biological fate of chemicals 20030701 |
| [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20030701 |
| The evolving management of migraine. | Current opinion in neurology 20030601 |
| [Improved pharmacokinetics. Fast tryptan with sustained response]. | MMW Fortschritte der Medizin 20030526 |
| [Highly selective beginning. Associated symptoms and side effects in retrospect]. | MMW Fortschritte der Medizin 20030526 |
| Eletriptan (relpax) for migraine. | The Medical letter on drugs and therapeutics 20030428 |
| Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. | Neurology 20030408 |
| Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States. | Headache 20030301 |
| Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. | Headache 20030301 |
| Cost-effectiveness of migraine treatment: a commentary. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101 |
| A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101 |
| Eletriptan issues. | Headache 20030101 |
| Sumatriptan versus eletriptan: which is best? | The Lancet. Neurology 20021201 |
| Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate. | Brain research 20021025 |
| Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. | Neurology 20021022 |
| New medications show promise for migraine sufferers. | Dentistry today 20021001 |
| Eletriptan Pfizer. | Current opinion in investigational drugs (London, England : 2000) 20020901 |
| Mechanisms of action of the 5-HT1B/1D receptor agonists. | Archives of neurology 20020701 |
| Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs. | Cephalalgia : an international journal of headache 20020701 |
| The pharmacokinetics and safety of single escalating oral doses of eletriptan. | Journal of clinical pharmacology 20020501 |
| Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration. | Journal of clinical pharmacology 20020501 |
| [Migraine has to be treated. Otherwise a stroke threatens]. | MMW Fortschritte der Medizin 20020214 |
| Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks. | Cephalalgia : an international journal of headache 20020201 |
| [New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain]. | MMW Fortschritte der Medizin 20020124 |
| Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. | European neurology 20020101 |
| Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers. | Journal of clinical pharmacology 20011201 |
| Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. | Lancet (London, England) 20011117 |
| Eletriptan. | Expert opinion on investigational drugs 20011001 |
| Triptans are all different. | Archives of neurology 20010901 |
| Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. | European journal of pharmacology 20010817 |
| Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. | Neurology 20010710 |
| [New potent serotonin receptor agonist. Helps migraine patients even when other triptans fail]. | MMW Fortschritte der Medizin 20010705 |
| Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). | Archives of neurology 20010701 |
| Pharmacology and efficacy of eletriptan for the treatment of migraine attacks. | International journal of clinical practice 20010601 |
| [Eletriptan shortly before drug approval. Fewer problems in migraine therapy]. | MMW Fortschritte der Medizin 20010528 |
| Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model. | Microscopy research and technique 20010501 |
| [Current topics: expectation for new triptans]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410 |
| Acute treatment of migraine and the role of triptans. | Current neurology and neuroscience reports 20010301 |
| pH-mediated field-amplified sample stacking of pharmaceutical cations in high-ionic strength samples. | Electrophoresis 20010101 |
| Eletriptan for acute migraine. | The Cochrane database of systematic reviews 20010101 |
| Eletriptan: pharmacological differences and clinical results. | Current medical research and opinion 20010101 |
| Comparative aspects of triptans in treating migraine. | Clinical cornerstone 20010101 |
| Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. | Acta neurologica Belgica 19990601 |
| Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. | European journal of pharmacology 19990305 |